Other identified inflammation-based scores were modified Glasgow prognostic score (mGPS, n = 5), lymphocyte-to-monocyte ratio (LMR, n = 2), monocyte-to-lymphocyte ratio (MLR, n = 2), advanced lung cancer inflammation index (ALI, n = 2), systemic immune-inflammation index (SII, n = 2), and haemoglobin, albumin, lymphocyte, and platelet score (HALP, n = 1). This evidence concerns the gene ALB and lung carcinoma.